Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Lymphocele
Interventions: DRUG: Lanreotide LP 90|DRUG: Placebo lanreotide
Sponsor: University Hospital, Limoges
Collaborators: Ipsen